Ixinity Purple Book BLA 125426

BLA number
125426
Proprietary names
Ixinity
Proper names
Coagulation Factor IX (Recombinant)
Applicant
Medexus Pharma, Inc.
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001IxinityCoagulation Factor IX (Recombinant)351(a)500IUFor InjectionIntravenousSingle-Dose VialDiscLicensed2015-04-29
002IxinityCoagulation Factor IX (Recombinant)351(a)1500IUFor InjectionIntravenousSingle-Dose VialRxLicensed2015-04-29
003IxinityCoagulation Factor IX (Recombinant)351(a)1000IUFor InjectionIntravenousSingle-Dose VialRxLicensed2015-04-29
004IxinityCoagulation Factor IX (Recombinant)351(a)250IUFor InjectionIntravenousSingle-Dose VialDiscLicensed2015-12-21
005IxinityCoagulation Factor IX (Recombinant)351(a)3000IUFor InjectionIntravenousSingle-Dose VialRxLicensed2015-12-21
006IxinityCoagulation Factor IX (Recombinant)351(a)2000IUFor InjectionIntravenousSingle-Dose VialDiscLicensed2015-12-21

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2026-06-01U001Ixinity351(a)DiscMedexus Pharma, Inc.
2024-07-01U004Ixinity351(a)DiscMedexus Pharma, Inc.
2024-07-01U006Ixinity351(a)DiscMedexus Pharma, Inc.
2021-06-01U001Ixinity351(a)RxMedexus Pharma, Inc.
2021-06-01U002Ixinity351(a)RxMedexus Pharma, Inc.
2021-06-01U003Ixinity351(a)RxMedexus Pharma, Inc.
2021-06-01U004Ixinity351(a)RxMedexus Pharma, Inc.
2021-06-01U005Ixinity351(a)RxMedexus Pharma, Inc.
2021-06-01U006Ixinity351(a)RxMedexus Pharma, Inc.
2021-05-01U001Ixinity351(a)RxAptevo BioTherapeutics LLC
2021-05-01U002Ixinity351(a)RxAptevo BioTherapeutics LLC
2021-05-01U003Ixinity351(a)RxAptevo BioTherapeutics LLC
2021-05-01U004Ixinity351(a)RxAptevo BioTherapeutics LLC
2021-05-01U005Ixinity351(a)RxAptevo BioTherapeutics LLC
2021-05-01U006Ixinity351(a)RxAptevo BioTherapeutics LLC
2020-08-01R001Ixinity351(a)RxAptevo BioTherapeutics LLC
2020-08-01R002Ixinity351(a)RxAptevo BioTherapeutics LLC
2020-08-01R003Ixinity351(a)RxAptevo BioTherapeutics LLC
2020-08-01R004Ixinity351(a)RxAptevo BioTherapeutics LLC
2020-08-01R005Ixinity351(a)RxAptevo BioTherapeutics LLC
2020-08-01R006Ixinity351(a)RxAptevo BioTherapeutics LLC

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2026-06-01001Ixinity351(a)DiscLicensed2015-04-29
2024-07-01004Ixinity351(a)DiscLicensed2015-12-21
2024-07-01006Ixinity351(a)DiscLicensed2015-12-21
2020-08-01001Ixinity351(a)RxLicensed2015-04-29
2020-08-01002Ixinity351(a)RxLicensed2015-04-29
2020-08-01003Ixinity351(a)RxLicensed2015-04-29
2020-08-01004Ixinity351(a)RxLicensed2015-12-21
2020-08-01005Ixinity351(a)RxLicensed2015-12-21
2020-08-01006Ixinity351(a)RxLicensed2015-12-21